tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market

BioMarin Pharmaceutical (BMRN) Income Statement

Compare
2,059 Followers

BioMarin Pharmaceutical Income Statement

Last quarter (Q4 2024), BioMarin Pharmaceutical's total revenue was $747.31M, an increase of 15.65% from the same quarter last year. In Q4, BioMarin Pharmaceutical's net income was $124.94M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.85B$ 2.42B$ 2.10B$ 1.85B$ 1.86B
Gross Profit
$ 2.27B$ 1.84B$ 1.61B$ 1.38B$ 1.34B
Operating Expenses
$ 1.79B$ 1.75B$ 1.57B$ 1.46B$ 1.43B
Depreciation and Amortization
$ 96.43M$ 104.39M$ 101.97M$ 108.04M$ 105.88M
EBITDA
$ 650.53M$ 310.28M$ 267.51M$ 48.03M$ -5.85M
Operating Income
$ 484.21M$ 194.44M$ 57.55M$ -60.01M$ -96.26M
Other Income/Expenses
$ 57.55M$ -5.88M$ 14.00K$ -15.34M$ -5.56M
Pretax Income
$ 541.76M$ 188.56M$ 149.58M$ -75.35M$ -42.32M
Net Income
$ 426.86M$ 167.65M$ 141.56M$ -64.08M$ 854.03M
Per Share Metrics
Basic EPS
$ 2.21$ 0.89$ 0.76$ -0.35$ 4.75
Diluted EPS
$ 2.13$ 0.87$ 0.75$ -0.35$ 4.53
Weighted Average Shares Outstanding
190.03M 187.83M 185.27M 182.85M 180.80M
Weighted Average Shares Outstanding (Diluted)
196.71M 191.59M 188.96M 182.85M 191.68M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis